Trump Promised Cheaper Drugs: Some Prices Fall, Others Jump
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
Tracking overspending involves straightforward methods like category budgets and regular reviews. Get started with easy steps to monitor and adjust your budget.
17,487 articlesAs of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
Peloton posted a GAAP profit in its latest quarter and raised full-year guidance, sparking an 11% premarket jump as i...
A16z publishes a sharp rebuttal to fears about a sweeping AI job apocalypse, framing the debate through the lens of t...
Two popular ETFs both target consumer staples, but their weighting methods lead to distinct risk and return profiles....
Coinbase stunned markets with an unexpected loss even as its newer businesses are scaling rapidly. This article expla...
European regulators are signaling caution on euro stablecoins as they stress structural risks. This article explains ...
Could Amazon pull ahead of the broader market? This article builds a disciplined case for why Amazon might outperform...
When market turbulence rises, even growth-focused firms recalibrate. Francis Financial doubles down on fixed income, ...
Cardano's ADA hovers near a pivotal support level as traders debate whether a renewed rally can unfold. The market is...
Morgan Stanley’s bitcoin ETF attracted $194 million in its first month, with no net daily outflows, signaling growing...
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
The apei 2026 earnings call offers crucial clues about enrollment momentum, cost discipline, and future guidance. Thi...